Phase I-II study of docetaxel and oxaliplatine in patients with stage III-IV ovarian epithelial cancer
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Docetaxel; Oxaliplatin
- Indications Ovarian cancer
- Focus Adverse reactions; Therapeutic Use
- 24 Jul 2008 Biomarkers information updated
- 05 Aug 2005 New trial record.